Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Low Anterior Resection Syndrome
2020-004442-11Phase 2Completed
- Sponsor
- Zealand University Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in low anterior resection syndrome (LARS), sponsored by Zealand University Hospital. Primary endpoint: LARS score. Started Oct 2020; status: completed.
02
Drugs
melatonin
03
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on 2020-004442-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004442-11.